Mind Medicine Inc (NASDAQ: MNMD) started the day on Thursday, with a price decrease of -5.96% at $10.25, before settling in for the price of $10.90 at the close. Taking a more long-term approach, MNMD posted a 52-week range of $2.41-$12.22.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 2.29%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.53%. This publicly-traded company’s shares outstanding now amounts to $41.10 million, simultaneously with a float of $26.94 million. The organization now has a market capitalization sitting at $288.64 million. At the time of writing, stock’s 50-day Moving Average stood at $7.31, while the 200-day Moving Average is $4.53.
Mind Medicine Inc (MNMD) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Mind Medicine Inc’s current insider ownership accounts for 4.34%, in contrast to 61.39% institutional ownership. According to the most recent insider trade that took place on Mar 25 ’24, this organization’s Chief Executive Officer sold 16,519 shares at the rate of 9.50, making the entire transaction reach 156,930 in total value, affecting insider ownership by 580,202. Preceding that transaction, on Mar 25 ’24, Company’s Chief Medical Officer sold 6,578 for 9.50, making the whole transaction’s value amount to 62,491. This particular insider is now the holder of 358,452 in total.
Mind Medicine Inc (MNMD) Earnings and Revenue Records
In the latest quarterly report released, which was put into the public domain on 12/30/2023, the organization reported -$0.59 earnings per share (EPS) for the three months, lower than the consensus estimate (set at -$0.46) by -$0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
Mind Medicine Inc’s EPS increase for this current 12-month fiscal period is 36.53% and is forecasted to reach -1.47 in the upcoming year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Let’s observe the current performance indicators for Mind Medicine Inc (MNMD). It’s Quick Ratio in the last reported quarter now stands at 3.22. The Stock has managed to achieve an average true range (ATR) of 1.04.
In the same vein, MNMD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.45, a figure that is expected to reach -0.42 in the next quarter, and analysts are predicting that it will be -1.47 at the market close of one year from today.
Technical Analysis of Mind Medicine Inc (MNMD)
If we take a close look at the recent performances of Mind Medicine Inc (NASDAQ: MNMD), its last 5-days Average volume was 1.62 million that shows plunge from its year to date volume of 2.01 million. During the previous 9 days, stock’s Stochastic %D was recorded 43.94% While, its Average True Range was 1.09.
Raw Stochastic average of Mind Medicine Inc (MNMD) in the period of the previous 100 days is set at 79.90%, which indicates a major rise in contrast to 39.32% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 108.49% that was lower than 108.72% volatility it exhibited in the past 100-days period.
